Accelerating Access to Life-Changing Therapies: The Role of Pharma Packaging
In the last decade, Cell and Gene therapies (CGTs) have emerged as a popular treatment option for complex diseases. Some of the factors contributing to this rapid growth include technological advancements in manufacturing techniques,...
The importance of GMP in ensuring the Quality and Safety of Complex Therapeutics
Good Manufacturing Practices (GMPs) are foundational in ensuring Quality and Safety in the biopharmaceutical industry. As therapeutics become ever more complex and as a consequence regulatory scrutiny increases, understanding how to apply GMPs is...
The data-driven revolution: How real-time analytics are transforming mRNA manufacturing
After slow market growth following the first RNA therapy launch in 1998 , recent clinical and commercial successes have propelled RNA therapeutics into the pharmaceutical spotlight. RNA therapeutics now offer revolutionary treatments for many...
Enhancing patient outcomes through a robust data infrastructure strategy
Every step of the biopharmaceutical process generates data — from development to manufacture to distribution. Capturing and centralizing that data can help the industry create and deliver medicines and treatments more quickly and efficiently,...
Quality Assurance & Quality Control In The Pharma of Today!
The pharmaceutical industry is one of the most highly regulated sectors globally, and for good reason. From discovery to commercialization, developing a new drug is a complex process that involves multiple stages of research,...
Addressing research problems for the long term requires a data-centric strategy
In research and development (R&D), scientists are generating more data now than ever before. But finding success in today's digital age requires the implementation of a company-wide data-centric architecture that addresses research problems from...
Holistic ADC Support: How CDMOs Can Help Navigate Bottlenecks of ADC Manufacturing
Antibody-drug conjugates (ADCs) are complex bioconjugates that combine a targeting antibody with a highly-potent payload using a linker molecule. This allows the delivery of nanomolar concentrations of a potent cytotoxic agent within a tumor...
QIAGEN’s role in advancing companion diagnostics for precision medicine
In the evolving landscape of healthcare, precision medicine has emerged as a game-changer, promising tailored treatments and improved patient outcomes. At the forefront of this revolution is QIAGEN, a global leader in Sample to...
Child-resistant packaging: navigating the delicate balance between security and inclusion
Within the highly regulated pharmaceutical industry, patient safety stands as an unwavering principle. Packaging design, in this context, assumes a critical role in safeguarding the well-being of individuals. Child-resistant closures, in particular, serve as...
Get Ready, Pharma: Drug Supply Chain Security Act (DSCSA) Enforcement Is At Hand
More than 10 years ago, Congress passed a law designed to protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. Up until now, it has never been fully...